GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.86 CNY | +3.03% |
|
+3.93% | -7.89% |
| 2023 | GuangYuYuan Makes Leadership Reshuffle | MT |
| 2023 | GuangYuYuan Chinese Herbal Medicine Co., Ltd.(SHSE:600771) added to Shanghai Stock Exchange Health Care Sector Index | CI |
| Sales 2021 | 854M 118M | Sales 2022 | 995M 137M | Capitalization | 13.62B 1.88B |
|---|---|---|---|---|---|
| Net income 2021 | -316M -43.61M | Net income 2022 | -399M -55.07M | EV / Sales 2021 | 24.9 x |
| Net Debt 2021 | 183M 25.22M | Net Debt 2022 | 187M 25.74M | EV / Sales 2022 | 13.9 x |
| P/E ratio 2021 |
-67.3
x | P/E ratio 2022 |
-34.3
x | Employees | 1,950 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 79.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.03% | ||
| 1 week | +3.93% | ||
| Current month | +0.93% | ||
| 1 month | +2.60% | ||
| 3 months | +10.88% | ||
| 6 months | -12.28% | ||
| Current year | -7.89% |
1 week
23.30
24.87
1 month
23.3026.22
Current year
20.9127.65
1 year
20.9144.00
3 years
16.2554.04
5 years
11.4854.04
10 years
11.4854.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Bo Wang
DFI | Director of Finance/CFO | 40 | 22-02-27 |
Li Qiao
IRC | Investor Relations Contact | 41 | 23-01-17 |
Yun Tang
SEC | Corporate Secretary | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yun Tang
SEC | Corporate Secretary | 52 | - |
Xuan Min Zhao
BRD | Director/Board Member | 69 | 20-01-14 |
Bo Yang
BRD | Director/Board Member | 50 | 23-01-17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 24.86 | +3.03% | 6 818 463 |
| 24-04-25 | 24.13 | +0.04% | 3,720,872 |
| 24-04-24 | 24.12 | -0.33% | 3,183,420 |
| 24-04-23 | 24.2 | +0.96% | 4,148,820 |
| 24-04-22 | 23.97 | +1.83% | 5,620,768 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
GuangYuYuan Chinese Herbal Medicine Co., Ltd. is a China-based company principally engaged in the manufacture and sale of traditional Chinese medicine and health wine. The Company's products types consist of traditional Chinese medicine, fine Chinese medicine and health wine, which include Dingkun Dan, Guilingji, Angong Niuhuang Pills and Niuhuang Qingxin Pills, among others. The Company distributes its products in domestic market.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.89% | 1.63B | |
| -15.13% | 4.49B | |
| -9.75% | 3.06B | |
| +2.14% | 3.04B | |
| -6.82% | 2.61B | |
| +47.87% | 1.81B | |
| +0.09% | 1.66B | |
| -12.97% | 1.55B | |
| +33.40% | 1.41B | |
| +34.29% | 1.34B |
- Stock Market
- Equities
- 600771 Stock
